高级检索
韦艳, 张海英, 梁钢. EGCG逆转肝癌耐多药差异基因表达[J]. 中国公共卫生, 2011, 27(5): 579-581. DOI: 10.11847/zgggws-2011-27-05-23
引用本文: 韦艳, 张海英, 梁钢. EGCG逆转肝癌耐多药差异基因表达[J]. 中国公共卫生, 2011, 27(5): 579-581. DOI: 10.11847/zgggws-2011-27-05-23
WEI Yan, ZHANG Hai-ying, LIANG Gang. Detection of differentially expressed genes reversing MDR of HCC induced by EGCG[J]. Chinese Journal of Public Health, 2011, 27(5): 579-581. DOI: 10.11847/zgggws-2011-27-05-23
Citation: WEI Yan, ZHANG Hai-ying, LIANG Gang. Detection of differentially expressed genes reversing MDR of HCC induced by EGCG[J]. Chinese Journal of Public Health, 2011, 27(5): 579-581. DOI: 10.11847/zgggws-2011-27-05-23

EGCG逆转肝癌耐多药差异基因表达

Detection of differentially expressed genes reversing MDR of HCC induced by EGCG

  • 摘要: 目的 探讨表没食子儿茶素没食子酸酯(EGCG)逆转人肝癌细胞耐多药的机制,为进一步在基因转录水平上高通量筛选逆转肝癌耐多药天然药物提供一定的参考依据。方法 采用人肝癌细胞Bel-7402及其耐5-氟尿嘧啶Bel-FU细胞,甲基四唑蓝法检测耐药Bel-FU细胞的耐多药性及对EGCG进行体外细胞毒性试验;选择与肝癌发生发展相关途径的42个功能基因作为检测基因,采用实时定量PCR微阵列技术检测Bel-7402组、Bel-FU组、Bel-FU+EGCG作用组基因表达;实时定量PCR检测相同条件下处理的基因Hras、MDR1表达变化以验证微阵列技术结果。结果 耐药细胞Bel-FU对5-氟尿嘧啶、阿糖胞苷、长春新碱、阿霉素、柔红霉素的耐药指数分别为:89.6、3.9、37.2、16.5、3.7;EGCG对细胞Bel-FU的IC50、IC10值分别为587.4、73.1μg/mL;实时定量PCR微阵列检测结果显示:与Be-7402组比较,Bel-FU组中有5个基因上调;与Bel-FU组比较,Bel-FU+EGCG作用组有5个基因下调,其中有3个基因为Bel-7402组与Bel-FU组之间的差异基因;实时定量PCR验证结果:Bel-FU组中基因Hras、MDR1表达为Bel-7402组中的2.84、2.74倍,与Bel-FU组比较,Bel-FU+EGCG组作用中基因Hras、MDR1表达分别下调3.21、3.74倍。结论 EGCG对人肝癌耐多药细胞Bel-FU具有一定逆转作用。

     

    Abstract: Objective To investigate the mechanism of reversing effect of epigalloca techin gallate(EGCG)on multi-drug resistance(MDR)of human hepa to cellular carcinoma(HCC)cell lines Bel-FU,and to provide the reference for screening natural drugs for reversing the MDR of HCC at transc riptional level.Methods Human HCC cell line BEL-7402 and multidrug-resistant HCC cell line Bel-Fu were cultured for the study.The MDR of Bel-Fu cells and its drug sensitivity to EGCG were determined by methyl thiazolyl tetrazolium(MTT)assay.Confined to the scope of the development of HCC,the 42 gene expression profiles of BEL-7402 group,BeL-FU group,and BeL-FU EGCG group were detected by real-time quantitative-PCR array.The expression profiles of gene Hras,MDR1 were comfirmed by real-time quantitative polym erase chain reaction.Results The resistance index(IR)of Bel-Fu to 5-fluo rouracil,cytarabine,vincristin,doxorubicin,daunorubicin was 89.6,3.9,37.2,16.5,and 3.7,respectively.The 50% inhibitory concentration(IC50)and 10% inhibitory concentration(IC10)of EGCG was 587.4μg/mL and 83.1 μg/mL,respectively.Compared with those in BEL-7402 group,5 differentially expressed genes were up-regulated in Bel-Fu group.Compared with those in Bel-Fu group,6 differentially expressed genes were down-regulated in Bel-Fu EGCG group.Compared with those in BEL-7402 group,the expression profiles of gene Hras and MDR1 in Bel-Fu group showed 2.7 and 2.74 times of increase.Compared with those in Bel-Fu group,the expression profiles of gene Hras and MDR1 in the Bel-Fu EGCG group decreased by 2.37 and 2.63 times.Conclusion EGCG could reverse the MDR of human hepatocellular carcinoma cell lines Bel-FU.

     

/

返回文章
返回